Wednesday, November 26, 2014 Last update: 1:03 PM
FreshNews.com - Covering Large & Obscure Tech Companies Since 1996

Par Pharmaceutical Companies, Inc.

News articles for Par Pharmaceutical Companies, Inc.:

Wednesday, November 12, 2014

Thursday, November 6, 2014

  • Par Pharmaceutical Announces Quarterly Conference Call
    WOODCLIFF LAKE, N.J., Nov. 6, 2014 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. announced today that it will host a conference call on Thursday, November 13, 2014 at 9:00 a.m. EST to review its results of operations for the third quarter ended September 30, 2014. Par is ... read more

Tuesday, September 30, 2014

  • Par Pharmaceutical Begins Shipment of Generic Exforge®
    WOODCLIFF LAKE, N.J., Sept. 30, 2014 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. today announced that it has begun shipping all four strengths of amlodipine and valsartan tablets, the generic version of Novartis' Exforge(®). Par received final approval from the U.S. Food and Drug Administration for its ... read more

Monday, September 8, 2014

  • Par Pharmaceutical Resumes Shipment of Generic Precedex® Injection
    WOODCLIFF LAKE, N.J., Sept. 8, 2014 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. today announced that it has resumed shipping dexmedetomidine hydrochloride (HCl) injection, EQ 100 mcg base/mL, the generic version of Hospira's Precedex(®) Injection. Par immediately resumed shipping after a U.S. District Court lifted a temporary ... read more

Wednesday, August 6, 2014

  • Par Pharmaceutical Announces Quarterly Conference Call
    WOODCLIFF LAKE, N.J., Aug. 6, 2014 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. announced today that it will host a conference call on Wednesday, August 13, 2014 at 10:00 a.m. EDT to review its results of operations for the second quarter ended June 30, 2014. Par is ... read more

Tuesday, June 10, 2014